WebDoctor Encyclopedia

Head & neck Primary bone tumours

Ameloblastic carcinoma

Ameloblastic carcinoma is the most common cancer arising from tooth-forming tissue in the jaw. It causes jaw swelling, pain or loose teeth, usually in middle age, and is treated with wide surgical removal and reconstruction, sometimes with radiotherapy.

Medically reviewed Last reviewed November 15, 2026

What is ameloblastic carcinoma?

Ameloblastic carcinoma is a rare cancer of the jaw that arises from the tissues that form teeth. These are called odontogenic tissues, and tumours that grow from them are called odontogenic tumours. Most odontogenic tumours are benign, but ameloblastic carcinoma is malignant: it can destroy bone, come back after treatment and, in some people, spread to other parts of the body.

It is the most frequent of the malignant odontogenic tumours, making up roughly three in ten of them (Robinson et al., 2024). Even so, it is very uncommon, and much of what is known comes from case reports and small series.

The tumour looks partly like an ameloblastoma, a benign but locally aggressive jaw tumour, but its cells show features of cancer. It may arise on its own (primary) or develop within an existing ameloblastoma (secondary).

Ameloblastic carcinoma usually affects adults in middle age, with an average age of about 45 in published reviews (Deng et al., 2019). The lower jaw (mandible) is affected more often than the upper jaw. Treatment is mainly surgery with wide margins, sometimes followed by radiotherapy.

1. Key facts at a glance

Feature Details
Type of cancer Malignant odontogenic (tooth-forming tissue) epithelial tumour
How common Very rare; a few hundred cases reported
Typical age Average mid-40s; wide range from children to older adults
Sex Reports differ; several series show more men
Main site Lower jaw, especially the back; upper jaw less often
Spread Mainly local; lungs are the commonest distant site
Main treatment Wide surgical removal of the affected jaw
Outlook Variable; recurrence is common and late spread can occur

2. Types of ameloblastic carcinoma

Type Description
Primary Arises as a cancer from the start
Secondary (intraosseous) Develops within a pre-existing ameloblastoma inside the bone
Secondary (peripheral) Develops from an ameloblastoma in the gum, outside the bone

In a review of 153 cases, whether the tumour was primary or secondary did not appear to change survival (Saluja and Hosalkar, 2018).

Feature Ameloblastoma Ameloblastic carcinoma Metastasising ameloblastoma
Cells Benign-looking Show cancer features Benign-looking
Growth Slow, locally aggressive Faster, more destructive Slow
Spread Does not spread Can spread to lungs and lymph nodes Spreads despite benign cells
Treatment Surgery Wider surgery, possible radiotherapy Surgery for each site

Where these tumours come from

Teeth develop from a special layer of cells in the jaw. The ameloblasts in this layer make enamel, the hard outer coating of the tooth. After the teeth have formed, small groups of these cells can remain trapped in the jaw bone or gum for life.

Term Meaning
Odontogenic Arising from tissues that form teeth
Ameloblast A cell that makes tooth enamel
Epithelial Made of lining-type cells rather than connective tissue
Intraosseous Inside the bone
Peripheral In the soft gum tissue, outside the bone

Ameloblastic carcinoma is thought to grow from these leftover tooth-forming cells, which is why it occurs almost only in the jaws.

3. Causes and risk factors

The cause is not known. Some ameloblastic carcinomas share gene changes with ameloblastoma, such as BRAF V600E mutations, and others carry additional changes linked to more aggressive behaviour.

Factor Notes
Existing ameloblastoma Especially if it has recurred many times or been present for years
Previous radiotherapy to the jaw Possible link in a few secondary cases
Middle age Most cases occur between 30 and 60
Lifestyle factors No clear link with smoking or alcohol
Inherited conditions None known

4. How does it look

In the mouth and face

Feature Description
Swelling A firm, enlarging swelling of the jaw or gum
Surface The gum may be normal, red or ulcerated
Teeth Loose or displaced teeth
Face Visible asymmetry when the tumour is large
Pain Present in about half of people

On X-rays and scans

Feature Description
Pattern A dark (radiolucent) area in the jaw, single or with several compartments
Borders Often ragged and ill-defined; some are well-defined
Bone Thinning or breaking through the outer layer of bone
Teeth Root resorption or displacement
Soft tissue Growth into the surrounding tissues on CT or MRI

In the large review by Robinson and colleagues, just over half of tumours had poorly defined borders, but a substantial minority looked well-defined and single-chambered, which can make them resemble benign cysts (Robinson et al., 2024).

Under the microscope

Feature Description
Basic pattern Islands of cells resembling ameloblastoma
Cancer features Enlarged, irregular nuclei, many dividing cells
Necrosis Areas of dead tumour tissue
Invasion Growth into bone, nerves or blood vessels
Ki-67 A high proliferation index in many cases

5. Symptoms

Common symptoms

  • A swelling of the jaw, often growing over months
  • Pain or tenderness in the jaw
  • Loose teeth or teeth moving out of position
  • Dentures that no longer fit

Less common symptoms

Symptom What it may mean
Numbness of the lip or chin Pressure on or invasion of the nerve in the lower jaw
A sore or ulcer on the gum Tumour breaking through the surface
Difficulty opening the mouth Spread into the chewing muscles
Nasal blockage or bleeding Upper jaw tumours growing into the sinus
Breathlessness or cough Rarely, spread to the lungs

When to seek medical advice

See a dentist or doctor if you have a swelling of the jaw, loose teeth without gum disease, numbness of the lip or chin, or a jaw lump that keeps growing. Most jaw swellings are not cancer, but these signs should be investigated.

6. Diagnosis

Test Purpose
Dental and mouth examination Assesses the swelling and teeth
Panoramic X-ray (OPG) First view of the jaw
CT scan Shows bone destruction and extent
MRI Shows soft-tissue and nerve involvement
Biopsy Confirms the diagnosis; review by a head and neck pathologist
Chest CT Checks for lung spread
PET-CT In selected cases, to look for distant spread

Conditions that can look similar

Condition Notes
Ameloblastoma Benign; cells lack cancer features
Odontogenic cysts Benign fluid-filled cavities
Squamous cell carcinoma of the mouth Usually starts on the surface lining
Other odontogenic cancers Such as clear cell odontogenic carcinoma
Metastasis from another cancer Spread to the jaw from elsewhere

Staging

There is no staging system specific to ameloblastic carcinoma. Many teams use the TNM system for oral cavity cancer to describe tumour size, lymph node involvement and distant spread.

7. Treatment

Treatment is planned by a head and neck cancer team, including maxillofacial surgeons, reconstructive surgeons, oncologists, dentists and speech and swallowing therapists.

Surgery

Procedure What it involves
Segmental mandibulectomy Removal of a full-thickness section of the lower jaw
Maxillectomy Removal of part of the upper jaw
Wide margins Healthy bone and tissue, often 1-2 cm, removed around the tumour
Neck dissection If lymph nodes are involved
Reconstruction Often with bone from the leg (fibula flap) or hip, sometimes with dental implants later

Simple scraping out (curettage) or local removal is associated with more recurrences, so wide resection is preferred. A review found that early surgery was linked to the best survival (Saluja and Hosalkar, 2018).

Jaw reconstruction explained

Option Description
Fibula free flap A section of the lower leg bone, with its blood supply, is shaped to replace the jaw
Hip (iliac crest) flap Bone from the hip, useful for some jaw shapes
Titanium plate Bridges the gap, sometimes as a temporary measure
Obturator A removable plate that fills a gap in the upper jaw and palate
Virtual surgical planning 3D scans used before surgery to plan cuts and shape the new jaw

Modern reconstruction aims to restore chewing, speech, swallowing and facial shape. Most people walk normally after a fibula flap, although the leg can feel weak or stiff for some weeks.

Radiotherapy

Situation Role
Positive or close margins To lower the risk of recurrence
Tumours that cannot be removed For local control
Spread to lymph nodes After neck surgery
Painful metastases For symptom relief

Drug treatment

Chemotherapy has a limited, uncertain role and is mainly used for widespread disease. For tumours with a BRAF V600E mutation, BRAF-targeted drugs have been tried in individual patients.

Side effects

Treatment Possible side effects
Jaw surgery Change in facial shape, numbness, difficulty chewing or speaking
Reconstruction Healing problems at the donor site, such as the leg
Radiotherapy Dry mouth, sore mouth, taste changes, risk of jaw bone damage (osteoradionecrosis)

What treatment involves day to day

Stage What to expect
Before surgery Dental assessment; damaged teeth may be removed
Hospital stay Often 1-2 weeks after jaw resection and reconstruction
Eating Soft or liquid diet at first, sometimes a feeding tube for a short time
Rehabilitation Speech and swallowing therapy, jaw exercises
Dental rehabilitation Implants or prostheses months later

8. Outlook (prognosis)

The outlook varies. Many people are cured by complete surgery, but recurrence is common, and the risk of recurrence keeps rising over many years of follow-up, while survival falls gradually (Robinson et al., 2024).

In a pooled analysis of 143 cases, recurrences were recorded in about a quarter and metastases in nearly a fifth (Deng et al., 2019).

Factor Effect on outlook
Complete removal with clear margins Better outcome
Older age Poorer survival
Upper jaw site May be harder to remove completely
Distant spread Poorer outlook
Conservative surgery Higher risk of recurrence

9. Follow-up

Follow-up Purpose
Clinic review every 1-3 months at first Checks the mouth, jaw and neck
CT or MRI of the jaw Looks for recurrence
Chest CT Looks for lung spread
Dental care Regular checks, especially after radiotherapy
Long-term follow-up Lifelong, because recurrence and spread can appear late

10. Living with ameloblastic carcinoma

  • See your dentist regularly and keep your mouth clean
  • Do jaw-stretching exercises as advised to prevent stiffness
  • Ask for dietitian support if eating is difficult
  • Avoid tooth extractions after radiotherapy without discussing it with your team
  • Report new swelling, pain, numbness or cough
  • Avoid smoking, which slows healing and harms reconstructed tissue
  • Keep a record of your scans and pathology, as follow-up may continue for many years
  • Tell your team about leg pain or stiffness after a fibula flap
  • Seek support for changes in appearance or speech from head and neck cancer groups

11. Frequently asked questions

Question Answer
Is it the same as ameloblastoma? No; ameloblastoma is benign, while ameloblastic carcinoma is a cancer
Is it a mouth cancer? It is a jaw bone cancer arising from tooth-forming tissue
Will I lose part of my jaw? Often, yes; reconstruction can restore shape and function
Can I have teeth afterwards? Dental implants or dentures are often possible later
Is it inherited? No
Who should treat it? A specialist head and neck or maxillofacial cancer team with experience of jaw tumours
Can it spread? Yes, most often to the lungs
Will I need radiotherapy? Only in some cases, such as close margins
How long is recovery after jaw surgery? Usually several weeks in hospital and at home, then months of rehabilitation
Will my face look different? There may be some change, but reconstruction aims to keep it as natural as possible

12. Questions to ask your care team

  • Is my tumour primary or secondary?
  • How much of my jaw will need to be removed?
  • What reconstruction do you recommend?
  • Were the margins clear?
  • Do I need radiotherapy?
  • Does my tumour have a BRAF mutation?
  • How often will I need scans?
  • Will I need dental work before treatment starts?
  • Who can help me with eating and speech afterwards?

Resources

  1. Deng, L. et al. (2019) ‘Ameloblastic carcinoma: clinicopathological analysis of 18 cases and a systematic review’, Head and Neck, 41(12), pp. 4191-4198.
  2. Robinson, L. et al. (2024) ‘Ameloblastic carcinoma: a systematic review’, Journal of Oral Pathology and Medicine, 53(3), pp. 174-181.
  3. Saluja, T.S. and Hosalkar, R. (2018) ‘Reconnoitre ameloblastic carcinoma: a prognostic update’, Oral Oncology, 77, pp. 118-124.
  4. National Cancer Institute (2026) Lip and Oral Cavity Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/head-and-neck/hp/adult/lip-mouth-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.